Person:
Ablon, John

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Ablon

First Name

John

Name

Ablon, John
Author's Publications: search.filters.isAuthorOfPublication.7bc11aa3-7bad-47d1-8313-3a0e67699ac2

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Patient and Practitioner Influences on the Placebo Effect in Irritable Bowel Syndrome
    (Ovid Technologies (Wolters Kluwer Health), 2009) Kelley, John; Lembo, Anthony; Ablon, John; Villanueva, Joel J.; Conboy, Lisa; Levy, Raymond; Marci, Carl; Kerr, Catherine; Kirsch, Irving; Jacobson, Eric; Riess, Helen; Kaptchuk, Ted
    Objective: To determine whether placebo responses can be explained by characteristics of the patient, the practitioner, or their interpersonal interaction. Methods: We performed an analysis of videotape and psychometric data from a clinical trial of IBS patients treated with placebo acupuncture in either a warm empathic interaction (Augmented, n=96), a neutral interaction (Limited, n=97), or a waitlist control (Waitlist, n=96). We examined the relations between placebo response and: (1) patient personality and demographics; (2) treating practitioner; and (3) the patient-practitioner interaction as captured on videotape and rated by the Psychotherapy Process Q-Set (PQS). Results: Patient extraversion, agreeableness, openness to experience, and female gender were associated with placebo response, but these effects held only in the augmented group. Regression analyses controlling for all other independent variables suggest that only extraversion is an independent predictor of placebo response. There were significant differences between practitioners in outcomes, and this effect was twice as large as the effect attributable to treatment group assignment. Videotape analysis indicated that the augmented group fostered a treatment relationship similar to a prototype of an ideal healthcare interaction. Conclusions: Gender and personality influenced placebo response, but only in the warm, empathic, augmented group. This suggests that to the degree a placebo effect is evoked by the patient-practitioner relationship, personality characteristics of the patient will be associated with placebo response. This finding may explain why consistent predictors of the placebo response have been difficult to detect. In addition, practitioners differed markedly in effectiveness, despite standardized interactions. We propose that the quality of the patient-practitioner interaction accounts for the significant difference between the groups in placebo response.